Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia

Shakeel Mowlaboccus; Denise A. Daley; Jacob Birdsall; Thomas Gottlieb; John Merlino; Graeme R. Nimmo; Narelle George; Tony Korman; Richard Streitberg; Jenny Robson; Georgia Peachey; Peter Collignon; Susan Bradbury; Benjamin A. Rogers; Geoffrey W. Coombs

doi:10.1016/j.cmi.2021.04.029

Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia

Shakeel Mowlaboccus, Denise A. Daley, Jacob Birdsall, Thomas Gottlieb, John Merlino, Graeme R. Nimmo, Narelle George, Tony Korman, Richard Streitberg, Jenny Robson, Georgia Peachey, Peter Collignon, Susan Bradbury, Benjamin A. Rogers, Geoffrey W. Coombs

Research output: Contribution to journal › Letter › Other › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1360-1361
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	27
Issue number	9
DOIs	https://doi.org/10.1016/j.cmi.2021.04.029
Publication status	Published - Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2021.04.029

Cite this

Mowlaboccus, S., Daley, D. A., Birdsall, J., Gottlieb, T., Merlino, J., Nimmo, G. R., George, N., Korman, T., Streitberg, R., Robson, J., Peachey, G., Collignon, P., Bradbury, S., Rogers, B. A., & Coombs, G. W. (2021). Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia. Clinical Microbiology and Infection, 27(9), 1360-1361. https://doi.org/10.1016/j.cmi.2021.04.029

@article{1a276d9a0a174e598415b2fa0ebb59d6,

title = "Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia",

author = "Shakeel Mowlaboccus and Daley, {Denise A.} and Jacob Birdsall and Thomas Gottlieb and John Merlino and Nimmo, {Graeme R.} and Narelle George and Tony Korman and Richard Streitberg and Jenny Robson and Georgia Peachey and Peter Collignon and Susan Bradbury and Rogers, {Benjamin A.} and Coombs, {Geoffrey W.}",

note = "Funding Information: BAR has consulted for Mayne Pharma with regard to the registration of fosfomycin in Australia with the Therapeutic Goods Administration. All other authors declare no competing interests. The fosfomycin antimicrobial surveillance study was funded by Mayne Pharma . Funding Information: BAR has consulted for Mayne Pharma with regard to the registration of fosfomycin in Australia with the Therapeutic Goods Administration. All other authors declare no competing interests. The fosfomycin antimicrobial surveillance study was funded by Mayne Pharma. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = sep,

doi = "10.1016/j.cmi.2021.04.029",

language = "English",

volume = "27",

pages = "1360--1361",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier",

number = "9",

}

Mowlaboccus, S, Daley, DA, Birdsall, J, Gottlieb, T, Merlino, J, Nimmo, GR, George, N, Korman, T, Streitberg, R, Robson, J, Peachey, G, Collignon, P, Bradbury, S, Rogers, BA & Coombs, GW 2021, 'Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia', Clinical Microbiology and Infection, vol. 27, no. 9, pp. 1360-1361. https://doi.org/10.1016/j.cmi.2021.04.029

TY - JOUR

T1 - Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia

AU - Mowlaboccus, Shakeel

AU - Daley, Denise A.

AU - Birdsall, Jacob

AU - Gottlieb, Thomas

AU - Merlino, John

AU - Nimmo, Graeme R.

AU - George, Narelle

AU - Korman, Tony

AU - Streitberg, Richard

AU - Robson, Jenny

AU - Peachey, Georgia

AU - Collignon, Peter

AU - Bradbury, Susan

AU - Rogers, Benjamin A.

AU - Coombs, Geoffrey W.

N1 - Funding Information: BAR has consulted for Mayne Pharma with regard to the registration of fosfomycin in Australia with the Therapeutic Goods Administration. All other authors declare no competing interests. The fosfomycin antimicrobial surveillance study was funded by Mayne Pharma . Funding Information: BAR has consulted for Mayne Pharma with regard to the registration of fosfomycin in Australia with the Therapeutic Goods Administration. All other authors declare no competing interests. The fosfomycin antimicrobial surveillance study was funded by Mayne Pharma. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85114029285&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2021.04.029

DO - 10.1016/j.cmi.2021.04.029

M3 - Letter

C2 - 33957274

AN - SCOPUS:85114029285

SN - 1198-743X

VL - 27

SP - 1360

EP - 1361

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 9

ER -

Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia

UN SDGs

Access to Document

Other files and links

Cite this